Wegovy 1.7mg FlexTouch Solution For Injection 3ml
In Stock • people bought this
- Weekly injection for weight management
- Mimics hormone to reduce cravings
- Supports sustainable weight control
- Flexible therapy with healthcare guidance
Delivery : 2-4 days PAN India
Seller : Davadost pharma private limited
People who purchased Wegovy 1.7mg FlexTouch Solution For Injection 3ml also bought
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Wegovy 1.7mg FlexTouch Solution For Injection 3ml
Wegovy 1.7mg FlexTouch Solution For Injection is a prescription injectable for chronic weight management, featuring semaglutide, a glucagon-like peptide‑1 (GLP‑1) receptor agonist. Delivered as a once-a-week shot, Wegovy supports adults (and eligible teens) with obesity (BMI ≥ 30) or overweight (BMI ≥ 27 with at least one comorbidity) in their journey toward healthier, more sustainable weight control.
Semaglutide mimics a natural hormone that signals fullness and slows digestion, reducing cravings and helping you eat less without feeling deprived. Clinical studies show that patients who reach maintenance doses—like 1.7 mg—lose significant weight over time, especially when combined with a balanced diet and regular physical activity. Stepping up gradually from 0.25 mg ensures your body adapts and minimizes side effects.
How Wegovy 1.7mg FlexTouch Solution For Injection 3ml works
Wegovy’s active component, semaglutide, mimics the hormone GLP‑1, which plays a key role in regulating hunger, digestion, and blood sugar. By binding to GLP‑1 receptors in the brain, it helps reduce appetite and limit food intake. Additionally, semaglutide slows gastric emptying, keeping you full longer after meals . It also enhances insulin release and lowers glucagon secretion in response to meals, improving glucose control. This combination reduces caloric intake, supports better metabolic function, and drives sustainable weight loss. Maintenance doses—such as 1.7 mg—are backed by clinical trials showing continued weight reduction and improved health markers.
How To Use Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Starting dose: 0.25 mg once weekly for 4 weeks.
- Escalation: increase monthly—0.5 mg (month 2), 1.0 mg (month 3).
- Month 4: increase to 1.7 mg once weekly.
- Inject subcutaneously (under skin) into your thigh, abdomen, or upper arm—rotate injection sites.
- Choose the same day of the week for each injection, anytime—food intake not required.
- Continue at 1.7 mg long‑term, or step up to 2.4 mg if advised and tolerated.
Special Precautions for Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Thyroid cancer risk: Individuals with medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should avoid Wegovy.
- Pancreatitis history: Report any severe abdominal pain promptly.
- Biliary issues: Rapid weight loss can increase gallstone risk.
- Retinopathy in diabetics: Monitor your eyes closely—semaglutide may worsen symptoms.
- Mental health: Rare mood changes reported—watch and discuss any concerns with your provider.
Benefits Of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Long‑term weight loss: Clinical studies show continued benefits at 1.7 mg, especially when maintained with 2.4 mg.
- Decreased appetite and cravings: Sustained reduction in hunger aids calorie control.
- Improved cardiometabolic health: Reduces risks for heart attack, stroke, and related events in overweight or obese adults with cardiovascular disease.
- Glucose regulation: Enhances insulin secretion and reduces glucagon, lowering blood sugar.
Side Effects Of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Gastrointestinal issues: nausea, vomiting, diarrhea, constipation, abdominal discomfort
- Metabolic: hypoglycemia in individuals on insulin/sulfonylureas
- Other: headache, fatigue, dizziness
- Serious side effects may include pancreatitis, gallbladder disease, injection-site reactions, temporary worsening of diabetic retinopathy
What If I Missed A Dose Of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
If you miss a dose of Wegovy:
- Take it as soon as possible if your next dose is over 48 hours away.
- Skip it if your next dose is within 48 hours—just take the next one as scheduled.
- If you miss doses for over 2 weeks, resume on your regular day or consult your healthcare provider.
Health And Lifestyle
Drug Interaction
- Insulin or sulfonylureas: Risk of hypoglycemia; blood glucose monitoring and dose adjustments required.
- Other oral meds: Slowed digestion may affect absorption—check with healthcare provider.
- Other GLP‑1s: Ozempic, Rybelsus—avoid overlapping semaglutide therapies.
Drug Food Interaction
- Alcohol: May worsen dehydration, GI upset, and impair weight‑loss progress.
- High-fiber meals: Could slow stomach emptying further—keep it consistent.
Disease Explanation
Obesity significantly raises the risk of chronic diseases—heart attacks, stroke, type 2 diabetes, high blood pressure, and fatty liver disease. Wegovy 1.7 mg addresses these by promoting fat loss, regulating energy intake, and improving metabolic signals. Its impact on cardiovascular outcomes makes it a sensible choice for comprehensive disease risk reduction in overweight individuals, beyond cosmetic or surface-level goals .
Safety Advice for Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- High risk
- Moderate risk
- Safe
Semaglutide doesn’t directly impact the liver, but dehydration can strain it.
Gastrointestinal discomfort like nausea, vomiting, or diarrhea can lead to dehydration and worsen kidney function.
No direct interactions with semaglutide have been reported, but alcohol can exacerbate nausea, dizziness, dehydration, and interfere with weight‑loss progress.
Some users may experience dizziness, fatigue, or low blood sugar (especially those with diabetes). Avoid driving until you know how Wegovy affects you.
There’s no confirmed human safety data, but animal studies showed a risk of fetal harm .
It's unknown whether semaglutide transfers to breast milk. To ensure infant safety, breastfeeding while on Wegovy is not recommended.
Tips for Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Advance slowly through doses to reduce side effects. Choose a consistent injection day to build routine. Rotate sites to prevent skin issues. Track health metrics—weight, blood sugar, blood pressure. Be flexible—adjust meals, beverage choices (ginger tea, crackers) if symptoms occur.
FactBox of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Active Ingredient: Semaglutide
- Brand and Strength: Wegovy 1.7 mg
- Drug Class: GLP‑1 receptor agonist
- Administration Route: Subcutaneous injection, once weekly
- Indications: Chronic weight management (BMI ≥ 30 or ≥ 27 with comorbidities), Cardiovascular risk reduction
Storage of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
Store your Wegovy pre‑filled pens in the refrigerator (2–8 °C). After first use, pens can be safely kept at room temperature (up to 30 °C) for 28 days. Protect from direct heat and light. Discard needles in a proper sharps container and follow local disposal guidelines.
Dosage of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
- Dosing Schedule: Start with 0.25 mg weekly (Weeks 1–4), then increase to 0.5 mg (Weeks 5–8), 1 mg (Weeks 9–12), 1.7 mg (Weeks 13–16), and maintain at 1.7 mg or escalate to 2.4 mg from Week 17 based on tolerance and response.
Synopsis of Wegovy 1.7mg FlexTouch Solution For Injection 3ml
Wegovy 1.7mg FlexTouch Solution For Injection is a potent, flexible weight‑loss therapy that leverages GLP‑1 mimetic action to curb appetite, support metabolic balance, and generate sustained fat reduction. It sits between introductory and full-dose maintenance levels and may be a long-term solution when paired with lifestyle improvements. Adhering carefully to the dosing schedule, accommodating side effects, and working closely with healthcare guidance ensures safety and maximizes outcome potential.
FAQ's on Wegovy 1.7mg FlexTouch Solution For Injection 3ml
1. Why is 1.7 mg considered maintenance?
2. Can I stay on 1.7 mg indefinitely?
3. Do results slow at this dose?
4. What injection technique is best?
5. How do I handle hunger on 1.7 mg?
6. Is routine bloodwork needed?
7. Can Wegovy slow digestion too much?
8. What should I do before surgery?
9. How do I restart if I miss weeks?
10. Are insurance or discounts available?
Written By
Priyanka Sonkushre
Content Updated on
Tuesday, 24 March, 2026
